Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 450.95
   
  • Change Today:
    $-2.41
  • 52 Week High: $455.99
  • 52 Week Low: $448.52
  • Currency: US Dollars
  • Shares Issued: 256.94m
  • Volume: 250,910
  • Market Cap: $115,867m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 450.95
Change Today $ -2.41
% Change -0.53 %
52 Week High $455.99
52 Week Low $448.52
Volume 250,910
Shares Issued 256.94m
Market Cap $115,867m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 8
Buy 11
Neutral 9
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 02-Jan-2026

Time Volume / Share Price
13:14 247 @ $450.95
13:13 40 @ $451.09
13:13 40 @ $451.02
13:13 40 @ $451.09
13:12 40 @ $451.06

Top of Page